Boehringer Ingelheim Biopharmaceuticals GmbH
Gesellschaft mit beschränkter Haftung (GmbH) · Ingelheim am Rhein, Germany · LEI 52990023HHM6EZ0SYR34
LEI active
Summary
Boehringer Ingelheim Biopharmaceuticals GmbH is registered in Germany and entered in the “Commercial Register (Handelsregister)” under number HRB 44283. Its legal form is Gesellschaft mit beschränkter Haftung (GmbH) – private limited company (Germany). According to GLEIF, its ultimate parent is C.H. Boehringer Sohn AG & Co. KG (Germany), which is also its direct parent. That group has 41 subsidiaries with LEIs in 16 countries, 18 of them in Germany. The LEI was first issued on 30 Dec 2013 and the record was last updated on 15 Nov 2025; the next renewal is due by 30 Dec 2026. AssetCensus found 1 data-quality note for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The ultimate-parent link rests on accounts for the period ending 31 Dec 2023, more than 24 months before this data release. The group may have changed since.
Company details
| Legal form | Gesellschaft mit beschränkter Haftung (GmbH) private limited company (Germany) |
|---|---|
| Register | Commercial Register (Handelsregister) · Register website |
| Registration number | HRB 44283 |
| Registration authority | Local Court Mainz |
| Jurisdiction | Germany |
| Registered address | Binger Straße 173, 55216 Ingelheim am Rhein, Germany |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 31 Oct 2012 |
| LEI | 52990023HHM6EZ0SYR34 |
| LEI status | active |
| LEI first issued | 30 Dec 2013 |
| LEI record last updated | 15 Nov 2025 |
| Next LEI renewal | 30 Dec 2026 |
| Corroboration of the LEI record | fully corroborated |
Group membership
Boehringer Ingelheim Biopharmaceuticals GmbH this entity
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | C.H. Boehringer Sohn AG & Co. KG | C.H. Boehringer Sohn AG & Co. KG |
| Accounting period | 1 Jan 2023 to 31 Dec 2023 | 1 Jan 2023 to 31 Dec 2023 |
| Evidence | consolidated accounts | consolidated accounts |
| Corroboration | fully corroborated | fully corroborated |
| Relationship start | 20 Nov 2017 | 20 Nov 2017 |
| Recorded at GLEIF since | 20 Dec 2017 | 20 Dec 2017 |
| Last updated | 15 Nov 2025 | 15 Nov 2025 |
| Record status | current | current |
Other subsidiaries of the same direct parent (40)
- Boehringer Ingelheim Animal Health International GmbH Germany
- Boehringer Ingelheim Animal Health Japan Holding GmbH Germany
- Boehringer Ingelheim Animal Health Participations GmbH Germany
- Boehringer Ingelheim Auslandsbeteiligungs GmbH Germany
- Boehringer Ingelheim Corporate Center GmbH Germany
- Boehringer Ingelheim Europe GmbH Germany
- Boehringer Ingelheim GmbH Germany
- Boehringer Ingelheim International GmbH Germany
- Boehringer Ingelheim Invest GmbH Germany
- Boehringer Ingelheim microParts GmbH Germany
- Boehringer Ingelheim Middle East & Africa GmbH Germany
- Boehringer Ingelheim Pharma GmbH & Co. KG Germany